TrialJAMA dermatology2026

Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.

Alexa B Kimball et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.